We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Grants Multiple Final Approvals for Arava Generics
FDA Grants Multiple Final Approvals for Arava Generics
September 20, 2005
Four generic drugmakers received final approval from the FDA Sept. 14 to market generic equivalents of sanofi-aventis’ rheumatoid arthritis treatment Arava (leflunomide) in 10- and 20-mg tablets.